Introduction {#s1}
============

*Listeria monocytogenes*, the causative agent of listeriosis in humans and animals, represents a major foodborne pathogen with serious impacts on public health and the food industry (de Valk et al., [@B6]; Popovic et al., [@B28]; Crim et al., [@B4]). Listeriosis mainly, but not exclusively affects neonates, elderly people, pregnant women, and immunosuppressed individuals and may cause gastroenteritis, sepsis, central nervous system infections, and abortion in pregnant women (Maertens de et al., [@B20]). Listeriosis, even though relatively rare, occurs worldwide (Maertens de et al., [@B20]) and is of major public health concern due to the high case-fatality rate in human clinical cases (15--30 deaths/100 cases; Crim et al., [@B4]; de Valk et al., [@B6]; Popovic et al., [@B28]). The ubiquitous nature of *L. monocytogenes* and its ability to grow at refrigeration temperatures (Walker et al., [@B37]) and to tolerate very low pH (reviewed in Smith et al., [@B34]) and high salt concentrations (Bergholz et al., [@B2]), increases the risk of foodborne outbreaks from strains that achieve high concentrations on products with a long shelf life and subsequently cause human infections upon consumption. Strains of *L. monocytogenes* can persist in niches within food processing facilities for years, representing a serious food safety issue (reviewed in Ferreira et al., [@B10]). As a preventive measure, quaternary ammonium compounds (QACs) such as benzalkonium chloride (BC), are widely used for cleaning and disinfection of food processing environments (McDonnell and Russell, [@B21]; Mereghetti et al., [@B22]). Quaternary ammonium compounds function by disrupting cell membranes of bacteria, subsequently leading to leakage of the cytosol, and degradation of proteins as well as nucleic acids (McDonnell and Russell, [@B21]). *L. monocytogenes* strains with low susceptibility to BC have been regularly isolated from foods and food processing environments. (Mereghetti et al., [@B22]; Romanova et al., [@B33]; Mullapudi et al., [@B24]; Fox et al., [@B11])., Benzalkonium chloride resistant (BC^r^) strains have been isolated from human listeriosis infections (Elhanafi et al., [@B9]), and there is evidence of cross-protection against other antimicrobials including gentamicin and ciprofloxacin (Rakic-Martinez et al., [@B30]). In light of this, the presence of BC^r^ strains in food and food processing environments is concerning.

The known molecular mechanisms of BC resistance are due to the activity of efflux pump systems encoded through the *brcABC* (Elhanafi et al., [@B9]), *qacH* on the Tn6188 transposon (Müller et al., [@B25]), and *emrE* (Gilmoure et al., [@B13]; Kovacevic et al., [@B18]) genes that can be acquired by horizontal gene transfer leading to BC resistance in *L. monocytogene*s. There is limited knowledge of the prevalence of BC resistance among Swiss *L. monocytogenes* strains; a recent study found a prevalence of 18% among 142 Swiss strains isolated from food and the food processing environment (Ebner et al., [@B8]). Virtually no information is available on the QAC resistance profiles in strains from Finland. The aim of this study was to analyze and compare a large collection consisting of *L. monocytogenes* strains from Switzerland and Finland for BC susceptibility and the presence of known genes that convey resistance to QAC. The strain collection included isolates originating from samples taken along the whole length of the food production chain, ranging from the farm environment (silage, feces of farm animals, birds, and veterinary clinical cases) to food production facilities and various foods to human clinical cases.

Materials and methods {#s2}
=====================

Bacterial strains
-----------------

The 392 *L. monocytogenes* strains used in this study were collected between 1999 and 2013 in Switzerland and Finland (Supplementary Table [1](#SM1){ref-type="supplementary-material"}). The Swiss strains (*n* = 195) were collected at the Swiss National Reference Centre for Enteropathogenic Bacteria and Listeria (NENT). This strain collection differed from that recently described in the study by Ebner et al. ([@B8]). Finnish strains (*n* = 197) were collected through the Department of Food Hygiene and Environmental Health of the Faculty of Veterinary Medicine at the University of Helsinki. Unlike the Swiss strain collection, the Finnish strain collection lacked human clinical isolates. The origin of the strains was summarized as: dairy (strains isolated from dairy products), meat (strains isolated from carcasses and raw meat products), fish (strains isolated from raw fish), ready to eat (RTE) food (strains isolated from RTE seafood, salad, sausage, ham, maize products), vegetables (strains isolated from raw vegetables), food animals (strains isolated from cows, goats, pigs, and sheep), birds (strains isolated from the feces of wild birds), food production environments (FPE; strains isolated from meat, RTE and dairy production environments), human (strains isolated from human listeriosis cases), others (strains isolated from quorn, rice, silage). Bacteria were stored at −80°C in brain heart infusion (BHI; Oxoid, Pratteln, Switzerland) broth plus 20% glycerol (Sigma-Aldrich, Buchs, Switzerland).

Strain serotyping and BC susceptibility testing
-----------------------------------------------

Strain serotypes were assigned by the slide agglutination test using the commercial set of Listeria O-factor and H-factor antisera from Denka Seiken (Pharma Consulting, Burgdorf, Switzerland) according to the manufacturer\'s instructions. Susceptibility to BC was tested using the previously described agar dilution method (Elhanafi et al., [@B9]). Strains were plated on blood agar plates (Difco, Columbia blood agar base, 5% sheep blood, Oxoid) and incubated for 18 h at 37°C. Single colonies were picked from each plate on the next day and suspended in 100 μl of Mueller Hinton broth (MHB; Oxoid, Pratteln, Switzerland). Five microliters of the suspensions were spotted in technical duplicates on Mueller Hinton Agar (MHA; Oxoid) plates supplemented with 2% defibrinated sheep blood (Oxoid) and various BC concentrations (0, 2.5, 5, 7.5, 10, 15, 20, 25, and 30 μg ml^−1^; Sigma-Aldrich). Benzalkonium chloride minimal inhibitory concentrations (MICs) were read after incubating the plates at 37°C for 48 h. Spots could exhibit either no growth, growth of individual colonies, or confluent growth over the full area of the spot. Strains were considered resistant to a given concentration of BC if the spots showed confluent growth, and the MIC was defined as the lowest BC concentration preventing confluent growth of the spotted bacteria. Strains were considered BC^r^ if they exhibited confluent growth at or above 20 μg ml^−1^. This cutoff was defined after the following considerations: we first determined the lowest BC concentration that killed \>50% of all strains (10 μg ml^−1^). Based on (Langsrud et al. ([@B19]); Xu et al. ([@B38]), we then defined resistance at a MIC that was double this concentration (20 μg ml^−1^). Minimal inhibitory concentrations are indicated as \>30 μg ml^−1^ for strains that exhibited confluent growth at 25 and 30 μg ml^−1^ BC.

Impact of efflux pump inhibition with reserpine on BC susceptibility
--------------------------------------------------------------------

To assess the contribution of efflux pump activity in BC^r^ strains, the BC MICs of such strains were also determined on MHB agar plates containing various BC concentrations (0, 2.5, 5, 7.5, 10, 15, 20, 25, and 30 μg ml^−1^; Sigma-Aldrich) and supplemented with the efflux pump inhibitor reserpine (20 μg ml^−1^; Sigma-Aldrich; Romanova et al., [@B32]). The BC resistance of the *L. monocytogenes* strains was classified as not efflux dependent (no effect of reserpine on the BC MIC), partially efflux pump dependent (addition of reserpine resulted in a decrease of the BC MIC of \<10 μg ml^−1^), or fully efflux pump dependent (addition of reserpine resulted in a decrease of the BC MIC of ≥10 μg ml^−1^).

Genetic analysis of all BC^r^ strains
-------------------------------------

The DNA templates were extracted from *L. monocytogenes* strains that were grown overnight in BHI broth (37°C and 125 rpm), using the DNeasy blood and tissue kit (Qiagen). Genotyping by multilocus sequence typing (MLST) was performed as previously described (Ragon et al., [@B29]). Polymerase chain reactions (PCRs) to amplify seven housekeeping genes were performed using the HotStartTaq Master Mix (Qiagen) and 50 ng of genomic DNA template from each analyzed strain. The PCR products were sequenced at Microsynth (Balgach). The MLST types and genetic lineages were assigned using the *L. monocytogenes* MLST database website (<http://bigsdb.web.pasteur.fr>). The PCR analysis for the presence of *bcrABC*, Tn*6188*, and *emrE* genes was performed as previously described using primers shown in Table [1](#T1){ref-type="table"}. The *emrE* primers were designed based on *L. monocytogenes* strain sequence 05--5578 described by Gilmoure et al. ([@B13]). The R56 and R159 *L. monocytogenes* strains (Ebner et al., [@B8]) were used as *bcrABC* and Tn*6188* positive controls, respectively whereas the LR39-1 strain (Kovacevic et al., [@B17]) was used as a positive control for *emrE*.

###### 

**Primers used in this study**.

  **Primer**   **Genetic target**   **Sequence (5′-3′)**              **References**
  ------------ -------------------- --------------------------------- ------------------------
  p1           *bcrABC*             CAT TAG AAG CAG TCG CAA AGC A     Elhanafi et al., [@B9]
  p2                                GTT TTC GTG TCA GCA GAT CTT TGA   
  radC fwd     *Tn6188*             CTT GCC AAT GAT AAT ATC ATC       Müller et al., [@B25]
  radC rev                          GTG GTC TGA ATG CTC CAT CG        
  EmrE fw      *emrE*               GAC CAA CAC CAC CTA AGT           This study
  EmrE rv                           GTC TGA TGG ACT TAC AAA GCT       

Statistical analysis
--------------------

Statistical analysis was performed using the JMP program (Version 11.0.0, SAS Institute Inc., NC, USA). Fisher\'s exact test was used in a series of individual pairwise comparisons using 2 × 2 tables to compare proportions of BC^r^ and BC^s^ within the serotypes and the sources per country. *P* \< 0.05 were considered to be statistically significant.

Results {#s3}
=======

Serotypes and origins of swiss and finnish *L. monocytogenes* strains
---------------------------------------------------------------------

A panel of 195 Swiss (CH) and 197 Finnish (FIN) *L. monocytogenes* strains that were isolated from diverse sources including foods, food production environments, food animals, wild birds, and human listeriosis cases was serotyped. Table [2](#T2){ref-type="table"} presents an overview of the distribution of these strains based on serotypes and isolation sources. Strains examined from these two countries belonged to serotypes 1/2a (CH: 105/195, 53.8%, and FIN: 134/197, 68.0%), 4b (CH: 47/195, 24.1%; FIN: 23/197, 11.7%), 1/2b (CH: 26/195, 13.3%; FIN: 18/197, 9.1%), 1/2c (CH: 17/195, 8.7%; FIN: 18/197, 9.1%), and 3a (CH: 1/195, 0.5%; FIN: 4/197, 2.0%). In terms of isolation sources, the Swiss strains came from human listeriosis (80/195, 41.0%), meat (59/195, 30.3%), RTE food (17/195; 8.7%), dairy (14/195, 7.2%), FPE (17/195, 8.7%), fish (2/195, 1.0%), food animals (1/195, 0.5%), vegetables (1/195, 0.5%), and other sources (4/195, 2.1%). Finnish strains originated from meat (69/197, 35%), FPE (31/197, 15.7%), fish (27/197, 13.7%), birds (25/197, 12.7%), food animals (19/197, 9.6%), raw vegetables (11/197, 5.6%), dairy (8/197, 4.0%), RTE food (3/197, 1.5%), and other sources (4/197, 2.0%).

###### 

**Distribution of the Swiss (CH) and Finnish (FIN) *L. monocytogenes* strains based on serotypes and sources**.

  **Source**                        **Number of *L. monocytogenes* strains within each serotype**                                                    
  --------------------------------- --------------------------------------------------------------- ------------ ----------- ---------- ------------ ------------
  **FOOD-ASSOCIATED ENVIRONMENT**                                                                                                                    
  CH                                9                                                               1            1           0          4            15
  FIN                               14                                                              8            7           0          2            31
  **DAIRY PRODUCTS**                                                                                                                                 
  CH                                10                                                              3            0           0          3            16
  FIN                               7                                                               0            0           1          0            8
  **RAW VEGETABLES**                                                                                                                                 
  CH                                1                                                               0            0           0          0            1
  FIN                               4                                                               5            0           1          1            11
  **RTE FOODS**                                                                                                                                      
  CH                                11                                                              4            0           0          2            17
  FIN                               2                                                               0            1           0          0            3
  **MEAT**                                                                                                                                           
  CH                                29                                                              6            10          0          14           59
  FIN                               54                                                              3            9           0          3            69
  **FISH**                                                                                                                                           
  CH                                1                                                               1            0           0          0            2
  FIN                               23                                                              0            0           2          2            27
  **FOOD ANIMALS**                                                                                                                                   
  CH                                1                                                               0            0           0          0            1
  FIN                               14                                                              1            0           0          4            19
  **BIRDS**                                                                                                                                          
  CH                                0                                                               0            0           0          0            0
  FIN                               13                                                              1            1           0          10           25
  **HUMAN LISTERIOSIS**                                                                                                                              
  CH                                41                                                              11           4           0          24           80
  FIN                               0                                                               0            0           0          0            0
  **OTHERS**                                                                                                                                         
  CH                                2                                                               0            1           1          0            4
  FIN                               3                                                               0            0           0          1            4
  Total (%)                         239 (61%)                                                       44 (11.2%)   34 (8.7%)   5 (1.3%)   70 (17.9%)   392 (100%)

BC susceptibility of the swiss and finnish *L. monocytogenes* strains
---------------------------------------------------------------------

The BC susceptibility profiles of the Swiss and Finnish *L. monocytogenes* strains were assessed. Benzalkonium chloride MICs ranging from 7.5 to \>30 μg ml^−1^ were found (Figure [1](#F1){ref-type="fig"}; Table [2](#T2){ref-type="table"}). Strains with BC MICs ≥20 μg ml^−1^ were classified as BC^r^; strains with BC MICs \<20 μg ml^−1^ were classified as BC^s^.

![**Distribution of the BC^r^ Swiss (CH) and Finnish (FIN) *L*.*monocytogenes* strains based on BC MICs**.](fmicb-08-00397-g0001){#F1}

By this definition, the majority (348 out of 392) of strains from both countries were BC^s^. There were however 24 (12.3%) Swiss and 21 (10.6%) Finnish strains classified as BC^r^, with BC MICs ranging from 20 to \>30 μg ml^−1^. The largest group within the Swiss strains (104/195; 53.3%) had BC MICs of 10 μg ml^−1^ whereas the largest group within the Finnish strains (96/197; 48.7%) had BC MICs of 7.5 μg ml^−1^.

Prevalence of BC^r^ strains with respect to isolation sources and serotypes
---------------------------------------------------------------------------

None of the dairy, food animal and other category strains from either Switzerland or Finland from this strain collection exhibited a BC^r^ phenotype. In both countries strains exhibiting BC^r^ phenotypes were recovered from the FPE, raw meat and RTE food categories. Swiss BC^r^ strains also included isolates from human listeriosis cases, whereas the Finnish BC^r^ strains included isolates from raw fish, vegetables, and wild birds. The prevalence of BC^r^ strains in both countries also varied with regard to the isolation sources (Figure [2A](#F2){ref-type="fig"}).

![**Bar charts depicting the prevalence (including 95% CIs) and distribution of BC^r^ among Swiss and Finnish *L*.*monocytogenes* strains based on (A)** isolation sources and **(B)** serotypes.](fmicb-08-00397-g0002){#F2}

The overall frequency of a BC^r^ phenotype in the Swiss strains was 12.3% and sources included, in descending order of relative frequency: FPE (5/17, 29.4%), meat (12/59, 20.3%), human isolates (6/80, 7.5%), and RTE food (1/17, 5.9%). The overall frequency of a BC^r^ phenotype in the Finnish strains was 10.2% and the sources included RTE (2/3, 66.7%), vegetables (3/11, 27.3%), the FPE (5/31, 16.1%), fish (3/27, 11.1%), and meat (4/69, 5.8%). Statistical analysis detected significant differences between the prevalence of a BC^r^ phenotype in Swiss vs. Finnish strains that were isolated from meat (CH \> FIN) and RTE (CH \< FIN) food products (*p* \> 0.05). It is possible that such differences might have been biased due to discrepancies in the number of tested strains since there were only three Finnish RTE food strains compared to 17 Swiss strains examined in this category. No significant (*p* \> 0.05) differences were detected in BC^r^ prevalence between the FPE, vegetables and raw fish strain categories in the two countries. BC^r^ strain prevalence in human listeriosis (6/80; 7.5%) and bird (3/24; 12.5%) categories in the two countries could however not be compared as they were not represented in both locations.

Prevalence of the BC^r^ strains also varied in each country with regard to the different *L. monocytogenes* serotypes. As expected given the composition of our strain collection, the majority of BC^r^ strains detected in both countries belonged to serotypes 1/2a (28/45, 62.2%) and 1/2c (12/45, 26.7%), although BC^r^ serotype 4b (3/45, 6.7%), and 1/2b (2/45, 4.4%) strains were also found. Interestingly, the highest prevalence of BC resistance was detected in serotype 1/2c strains from both countries (CH 4/16, 25%; FIN 7/18, 38.9%; Figure [2B](#F2){ref-type="fig"}). The second highest BC^r^ prevalence in Swiss strains was found in serotype 1/2a strains (19/105, 18.1%), and in Finnish strains among serotype 4b strains (3/23, 13%; Figure [2B](#F2){ref-type="fig"}). Low prevalence of BC resistance was found in serotype 1/2b isolates from both countries (CH: 1/26, 3.8%; FIN: 1/18, 5.5%), and no BC^r^ phenotypes were detected in Swiss serotype 4b (*n* = 47), as well as serotype 3a (*n* = 5) strains from both countries. Statistical comparison revealed significantly higher BC^r^ prevalence among the Swiss (19/105, 18.1% vs. 10/134, 7.5%; *p* \< 0.05) serotype 1/2a strains compared to their Finnish counterparts. On the other hand the Swiss serotype 4b strains displayed significantly lower BC^r^ prevalence (0 vs. 13%; *p* \< 0.05) compared to those from Finland. No significant differences were observed in BC^r^ prevalence associated with serotype 1/2c and 1/2b strains from the two countries. We are however aware that our observations could be biased due to overall differences in the examined sample sizes between some of the serotype categories in the two countries.

Genotypes associated with swiss and finnish BC^r^ strains
---------------------------------------------------------

Molecular genotypes associated with the Swiss and Finnish BC^r^ strains were assessed based on MLST genotyping. The 45 BC^r^ strains from the two countries were assigned to 14 sequence types (ST), which included two newly described sequence types (ST25, ST28; Table [3](#T3){ref-type="table"}). BC^r^ strains in both countries belonged predominantly to sequence types ST121 (14/45; 31.1%) and ST9 (11/45; 24.4%) although there were some country specific differences. Sequence type 121 (50 vs. 19%) predominated among the Swiss BC^r^ strains while ST9 (28.6 vs. 20.8%) was predominant in Finnish BC^r^ strains. Sequence types ST403 (*n* = 4), ST204 (*n* = 1), ST25 (*n* = 1), and ST 28 (*n* = 1) were exclusive to Swiss BC^r^ strains whereas ST155 (*n* = 3), ST1 (*n* = 1), ST101 (*n* = 1), ST120 (*n* = 1), ST194 (*n* = 1), and ST515 (*n* = 1) were exclusive to the Finnish BC^r^ strains. Strains were grouped into 10 MLST clonal complexes based on their sequence types showing that BC^r^ in this strain collection is mainly associated with serotype 1/2a, CC121 (16/45; 35.6%) and serotype 1/2c, CC9 (11/45, 24.4%). Overall, most BC^r^ strains belonged to evolutionary genetic lineage II (39/45; 86.7%). There were only five (11.1%) genetic lineage I BC^r^ strains observed, one of which was isolated in Switzerland and four were from Finland. One serotype 1/2c strain that originated from a FPE in Finland was untypable using the current MLST scheme. In this strain, primers for one (*bglA*) out of the seven MLST genes amplified a PCR product bearing a sequence that is unrelated to the *L. monocytogenes bglA* gene.

###### 

**Overview of the Swiss (CH) and Finnish (FIN) BCr strains detected in this study**.

  **Strain ID**   **Strain origin**   **Serotype**       **MLST genotypes[^a^](#TN1){ref-type="table-fn"}**   **BC MIC μgml^−1^**   **Efflux pump dependency[^b^](#TN2){ref-type="table-fn"}**   **BCr gene[^c^](#TN3){ref-type="table-fn"}**                           
  --------------- ------------------- ------------------ ---------------------------------------------------- --------------------- ------------------------------------------------------------ ---------------------------------------------- ------ ------ --------- ----------
  LM116           FIN                 Vegetable          1/2b                                                 CC5                   ST5                                                          1                                              25     30     No        Unknown
  N12-2082        CH                  Human              1/2a                                                 CC8                   ST8                                                          2                                              25     30     No        Unknown
  LT25E           FIN                 Vegetable          4b                                                   CC1                   ST515                                                        1                                              30     30     No        Unknown
  LL17/3          FIN                 Wild bird, feces   4b                                                   CC1                   ST1                                                          1                                              \>30   30     Partial   Unknown
  LT30E           FIN                 Vegetable          1/2a                                                 CC8                   ST8                                                          2                                              25     20     Partial   Unknown
  TT107E          FIN                 Fish               1/2a                                                 CC155                 ST155                                                        2                                              20     15     Partial   Unknown
  N13-0094        CH                  Human              1/2a                                                 CC403                 ST403                                                        2                                              25     20     Partial   Unknown
  N12-1667        CH                  FPE                1/2a                                                 CC403                 ST403                                                        2                                              25     20     Partial   Unknown
  N11-1547        CH                  Human              1/2a                                                 CC403                 ST403                                                        2                                              25     20     Partial   Unknown
  N12-0935        CH                  Human              1/2a                                                 CC403                 ST403                                                        2                                              25     20     Partial   Unknown
  TT82E           FIN                 Fish               1/2a                                                 CC155                 ST155                                                        2                                              25     15     Yes       Unknown
  HT45E           FIN                 Meat               1/2a                                                 CC155                 ST155                                                        2                                              20     10     Yes       Unknown
  LL66/3          FIN                 Wild bird, feces   1/2a                                                 CC101                 ST101                                                        2                                              20     7.5    Yes       Unknown
  LL1/3           FIN                 Wild bird, feces   4b                                                   CC315                 ST194                                                        2                                              20     5      Yes       Unknown
  LM84            FIN                 RTE food           1/2a                                                 CC8                   ST120                                                        2                                              25     30     No        *emrE*
  LK60/1          FIN                 Fish               1/2a                                                 CC121                 ST121                                                        2                                              25     30     No        *qacH*
  N11-1905        CH                  Meat               1/2a                                                 CC121                 ST121                                                        2                                              25     30     No        *qacH*
  HL6E            FIN                 FPE                1/2c                                                 untypable             untypable                                                    ND                                             20     20     No        *qacH*
  HE152E          FIN                 FPE                1/2c                                                 CC9                   ST9                                                          2                                              20     20     No        *qacH*
  HT93E/1         FIN                 RTE food           1/2c                                                 CC9                   ST9                                                          2                                              20     20     No        *qacH*
  HT100E/1        FIN                 Meat               1/2c                                                 CC9                   ST9                                                          2                                              20     20     No        *qacH*
  L34-s           FIN                 Meat               1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *qacH*
  MJL14           FIN                 FPE                1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *qacH*
  HT65E/1         FIN                 Meat               1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *qacH*
  N13-0119        CH                  Human              1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *qacH*
  N12-0367        CH                  Human              1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *qacH*
  Lm 760          CH                  Meat               1/2c                                                 CC9                   ST9                                                          2                                              20     20     No        *qacH*
  N11-2543        CH                  FPE                1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *qacH*
  N12-0571        CH                  Meat               1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *qacH*
  Lm S1           CH                  FPE                1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *qacH*
  N11-1218        CH                  Meat               1/2a                                                 CC121                 ST25                                                         2                                              \>30   30     Partial   *qacH*
  HT69E           FIN                 Meat               1/2c                                                 CC9                   ST9                                                          2                                              20     15     Partial   *qacH*
  HE28E           FIN                 FPE                1/2c                                                 CC9                   ST9                                                          2                                              25     20     Partial   *qacH*
  Lm 217          CH                  Meat               1/2a                                                 CC9                   ST9                                                          2                                              25     20     Partial   *qacH*
  Lm 25/9         CH                  Meat               1/2c                                                 CC9                   ST9                                                          2                                              20     15     Partial   *qacH*
  Lm 89           FIN                 FPE                1/2c                                                 CC9                   ST9                                                          2                                              25     20     Partial   *qacH*
  N12-0494        CH                  Meat               1/2a                                                 CC121                 ST121                                                        2                                              25     20     Partial   *qacH*
  N12-2229        CH                  RTE food           1/2a                                                 CC121                 ST121                                                        2                                              25     30     No        *brcABC*
  N12-0644        CH                  Meat               1/2c                                                 CC9                   ST9                                                          2                                              \>30   \>30   No        *brcABC*
  N12-2271        CH                  Meat               1/2c                                                 CC9                   ST9                                                          2                                              \>30   \>30   No        *brcABC*
  N12-2118        CH                  Meat               1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *brcABC*
  N13-0288        CH                  Meat               1/2a                                                 CC121                 ST28                                                         2                                              30     30     No        *brcABC*
  N13-0369        CH                  Meat               1/2a                                                 CC121                 ST121                                                        2                                              30     30     No        *brcABC*
  Lm S9           CH                  FPE                1/2a                                                 CC204                 ST204                                                        2                                              \>30   \>30   No        *brcABC*
  Lm S2           CH                  FPE                1/2b                                                 CC5                   ST5                                                          1                                              \>30   30     No        *brcABC*

*MLST types and genetic lineages were assigned based on the L. monocytogenes MLST database website (<http://bigsdb.web.pasteur.fr>)*.

*Efflux pump dependency: yes: BC MIC decreases by ≥10 μg ml^−1^ in the presence of the efflux pump inhibitor reserpine. Partial: BC MIC decreases by \<10 μg ml^−1^ in presence of reserpine. No: BC MIC was not affected by the presence of reserpine*.

*BC^r^ gene presence determined by PCR*.

Prevalence of BC resistance genes in swiss and finnish BC^r^ strains
--------------------------------------------------------------------

Benzalkonium chloride resistant strains were also examined for the distribution of genes encoding the three efflux pump systems (*brcABC, qacH*, and *emrE*) currently known to confer BC resistance in *L. monocytogenes* (Table [3](#T3){ref-type="table"}). The PCR-based analysis detected genes associated with such efflux pump systems in 79% (19/24) Swiss and 57% (12/21) Finnish BC^r^ strains, respectively. Swiss strains harbored both *qacH* (11/24; 45.8%) and *brcABC* (8/24, 33.3%) associated genes, and no strains harboring *emrE* were found. A majority of the BC^r^ strains from Finland harbored *qacH* genes (11/21; 52.4%), no *bcrABC* genes were found, and in one BC^r^ strain, an *emrE* gene was detected. With respect to associated serotypes and MLST genotypes, the *qacH* genes were detected in serotype 1/2a, CC121 (ST121 and ST28), serotype 1/2a, CC204 (ST204), and serotype 1/2c, CC9 (ST9) strains. The *brcABC* genes were associated with serotype 1/2a, CC121 (ST121 and ST25), serotype 1/2b, CC5, and serotype 1/2c, CC9 strains. The *emrE* gene was associated with a serotype 1/2a, CC8 (ST120) strain. In terms of origins, the *qacH*-encoding strains came from FPE, raw meat, fish RTE food, and human listeriosis cases. The *brcABC* harboring strains were from FPE and raw meat, and the *emrE* strain originated from an RTE food product. None of the three known BC resistance determinants were detected in 21% (5/24) and 43% (9/21) of the Swiss and Finnish BC^r^ strains, respectively (Table [3](#T3){ref-type="table"}). This group included serotype 4b, CC1 (ST1 and ST515), serotype 1/2a, CC8 (ST8), CC101 (ST101), CC155 (ST155), and serotype 1/2b, CC5 (ST5) strains, which were isolated from diverse sources. At this stage, sequence alterations affecting PCR primer binding sites across different strains cannot be completely ruled out as a possible reason for false negative results in some of the BC^r^ strains found to lack the known BC^r^ genes.

Role of efflux pump activity in swiss and finnish BC^r^ strains
---------------------------------------------------------------

A screen with reserpine showed that the BC resistance in 4 out of 45 strains depended on reserpine sensitive efflux pump systems. The BC resistance in an additional 14 strains was classified as partially efflux pump dependent while the addition of reserpine had no effect on the BC MIC in 27 strains. As mentioned above, a subset of 14 BC^r^ strains lacked known BC resistance genes. Reserpine addition had no impact on BC MICs in four of those strains. The BC resistance in an additional three strains was classified as efflux pump dependent, and in seven strains as partially efflux dependent. (Table [3](#T3){ref-type="table"}).

Discussion {#s4}
==========

In this study 392 *L. monocytogenes* strains recovered from human clinical listeriosis, food products and production environments, food animals, and wild birds in Switzerland and Finland were analyzed with respect to BC resistance. The strain collections could not be exactly matched or balanced with respect to origin, due to country specific differences in the type of food typically produced and limited availability of isolates. Although it remains unclear how well the strain collection represents the true distribution of strains in these two geographical locations, the large number of strains included in this study is likely to balance some of the potential bias. The vast majority of analyzed strains belonged to serotype 1/2a, 1/2b, 1/2c, and 4b, which are typical *L. monocytogenes* serotypes found in food, the food processing environment and human clinical cases (Orsi et al., [@B26]).

The prevalence of BC^r^ strains of 11.4% amongst our strains is at the lower end of what other authors have found. In comparison, prevalences of BC-resistant strains determined in other studies range from \~10% in strains isolated from fish and poultry factories (Aase et al., [@B1]), human clinical cases and food (Mereghetti et al., [@B22]; Ratani et al., [@B31]); 18--26% in strains isolated from food in Switzerland (Ebner et al., [@B8]) and China (Xu et al., [@B38]; Jiang et al., [@B16]) to 61% in strains originating from fish processing (Soumet et al., [@B35]) and the human clinical, food, and food production environment (Mullapudi et al., [@B24]; Dutta et al., [@B7]). These differences are partially due to the different methods used as well as differences in the definition of resistance across studies. The range of cutoffs for BC-resistance from 4 to 16 μg ml^−1^ in these studies (Aase et al., [@B1]; Mereghetti et al., [@B22]; Soumet et al., [@B35]; Mullapudi et al., [@B24]; Dutta et al., [@B7]; Xu et al., [@B38]; Ebner et al., [@B8]; Jiang et al., [@B16]) is a consequence of the commonly used method to determine BC-resistance relative to the MIC that inhibits a majority of strains. Working concentrations of BC in commercial products used in the food processing environment typically range from 500 to 1,000 μg ml^−1^ (Hegstad et al., [@B15]). However, *L. monocytogenes* preferably survives in niches with low accessibility for cleaning where the actual concentration of disinfectants is hard to predict. Defining relative cutoffs for BC-resistance is therefore a reasonable approach to focus on the strains that are most likely to have a selective advantage during repeated disinfection procedures.

There was no clear correlation between resistance to BC and country of origin. In our study, serotype 1/2a comprised the largest number of BC^r^ strains although the relative prevalence of BC^r^ was highest among the serotype 1/2c strains. Other authors have found varying fractions of BC^r^ serotype 1/2a, 1/2b, 1/2c, and 4b strains of *L. monocytogenes* (ranging from 7 to 60% for serotype 1/2a; from 0 to 51% for serotype 1/2b; from 22 to 75% for serotype 1/2c and from 0 to 100% for serotype 4b; Mereghetti et al., [@B22]; Romanova et al., [@B33]; Soumet et al., [@B35]; Mullapudi et al., [@B24]; Ratani et al., [@B31]; Xu et al., [@B38]; Jiang et al., [@B16]). This wide range is to be expected, given the often relatively small sample sizes and the low discriminatory power of serotyping (Datta et al., [@B5]).

In contrast, analysis by MLST revealed that CC121 and CC9 are overrepresented among BC^r^ strains carrying *brcABC* and *qacH* genes, which confirms the results of an earlier Swiss study (Ebner et al., [@B8]). Both of these clonal complexes are commonly found worldwide in association with food and clinical cases (Chenal-Francisque et al., [@B3]). A large study analyzing the population biology of 1696 strains of *L. monocytogenes* by core genome MLST indicated a broad range of strains carrying *brcABC* and *qacH* genes (including a cluster of CC121 strains) while *emrE* seems to be limited to sublineage 8 strains (comprising CC8, ST120; Moura et al., [@B23]). Incidentally, the only strain in our panel carrying the *emrE* gene also belongs to CC8, ST120. None of the BC^r^ strains lacking *brcABC, emrE*, and *qacH* belonged to CC121 or CC9. Instead, these strains belong to a more diverse set of seven sequence types including a cluster of four CC403 strains, a clonal complex that seems to be relatively rare and largely found in Europe with only five entries in the MLST database of the Institute Pasteur (<http://bigsdb.web.pasteur.fr>).

Our dataset provides several lines of evidence for mechanisms of BC resistance other than the known efflux pumps that may work either alone or in conjunction with the products of the *bcrABC, qacH*, and *emrE* genes. (i) Fourteen BC^r^ strains carried none of the known BC efflux pumps as determined by PCR. (ii) In eleven of these strains, reserpine screening indicated that efflux pumps other than those coded by *emrE, bcrABC*, and *qacH* play at least a partial role in conferring resistance to BC. (iii) Out of the 31 BC^r^ strains carrying genes encoding for known efflux pumps, 24 showed no reduction of the BC MIC in the presence of reserpine. This may indicate the presence of additional, yet unknown genes that confer BC resistance via a mechanism other than efflux pumps in these strains. Alternatively, reserpine may not be equally effective against all efflux pumps. In fact, other authors (Ortiz et al., [@B27]) found no difference in BC MIC after the addition of reserpine in a strain carrying the Tn6188 transposon (coding for *qacH* Müller et al., [@B25]), and a study analyzing efflux pumps conferring multidrug resistance to *Staphylococcus aureus* showed that reserpine failed to identify their presence in a considerable number (72/128, 61%) of strains (Frempong-Manso et al., [@B12]). While the addition of reserpine might not be a reliable method to exclude the presence of efflux pumps, in instances where it does exert an effect on the MIC of a given antimicrobial the presence of efflux pumps can be assumed (Godreuil et al., [@B14]; Soumet et al., [@B35]; Romanova et al., [@B32]; Xu et al., [@B38]).

Further, analysis of the BC^r^ strains in our panel that do not code for *bcrABC, qacH*, and *emrE* genes might help identify these additional factors involved in BC resistance. For instance, increased transcription of the multidrug resistance transporter *lde* has been reported in response to BC (Rakic-Martinez et al., [@B30]). Other than the activity of efflux pumps, modifications of the cell wall may potentially increase tolerance of BC by *L. monocytogenes* (McDonnell and Russell, [@B21]). This is supported by evidence from several studies: Mereghetti et al. ([@B22]) observed an association between BC resistance and failure of phage-based subtyping methods, which may indicate modifications in the wall teichoic acids. In addition, transcriptional analysis of the response to QAC revealed upregulation of peptidoglycan synthesis pathways (Fox et al., [@B11]), and To et al. ([@B36]) found a shift in fatty acid composition in one BC-adapted strain compared to the parent strain.

In conclusion, BC^r^ strains of *L. monocytogenes* are present and should be monitored in the Swiss and Finnish food production environment with a special focus on strains that belong to CC9 and CC121. One strain from Finland carried the *emrE* gene, which to our knowledge is the first time the *emrE* gene has been described in a strain of *L. monocytogenes* originating outside of Canada. Additionally, we found BC resistance in strains lacking all of the known BC resistance genes, indicating the presence of yet unknown mechanisms of BC resistance.
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